I. Firmino*

发表

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

M. Freedman, T. Ziemssen, K. Thangavelu, 2020, Multiple sclerosis journal - experimental, translational and clinical.